Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Advocates often stress the possibility for substantial therapeutic gains, especially in diseases where conventional treatments have proven ineffective. However, this is to consider the substantial financial expenditure associated with CPI stem cell the